The pandemic has caused them to try to find formulas against the coronavirus at all costs, with a special role for the vaccine and its different variants. However, while this race continues to find a victory, products that reduce the risk of contagion are already beginning to be marketed. One of them is the Taffix nasal spray, which protects against covid-19 for five hours and can already be found in some Spanish pharmacies.
It is not a substitute for the mask nor is it 100% effective, but this nasal spray is one of the most successful drugs in the fight against the coronavirus. A powder spray developed by the pharmaceutical company Nasus Pharma and capable of preventing the entry of 99.99% of respiratory viruses (including SARS-CoV-2.
Taffix is number 1 in sales on Amazon while it is already in some Spanish pharmacies
With a protection against covid-19 of around 78%, Taffix has a durability of five hours in which it blocks entry into the nasal cavity with an “additional layer to the masks”. A supplement developed in Israel and that is already beginning to be found in the first Spanish pharmacies, as well as on Amazon, so it does not need a medical prescription.
While , the batch of in the American multinational where it is number 1 in sales. In addition, in some pharmacies it is already beginning to be found for 13.75 euros, although it is difficult to find.
“Taffix is particularly useful in high-risk environments such as public transport, shops, concerts and closed spaces in general”, they have pointed out from Nasus Pharma where they ensure that the powders they contain are so discreet that they detect that the dose has been supplied ” menthol has been added.
The first item, beyond the mask, is certainly effective against covid-19 but, yes, it should not be administered to mucous membranes with wounds, in patients with hypersensitivity or in children under 12 years of age without first consulting a pediatrician.
Taffix could have a Spanish competitor
For its part, a group of scientists from the Catholic University of Valencia (UCV) is developing a similar drug that, using carbon nanomaterials and benzalkonium chloride, manages to disable the virus. In this case, setting the duration limit to eight hours would create a film in the nostril that would eliminate any virus that tried to enter it.
“Research in antivirals should continue once the current pandemic ends because, if we are able to find long-lasting antivirals, these will allow us to contain possible future epidemic outbreaks that are predicted to occur”, explained the head of the Structural Biochemistry Laboratory of the UCV, José Gallego.
“If we are able to find long-lasting antivirals, these will allow us to contain possible future epidemic outbreaks”
A project that is still in the experimental phase, but for which it is already collaborating with the University of Louisiana (United States). There, the pharmaceutical company Pan Therapeutics is working on obtaining a marketing license that, once approved, would compete directly with the Taffix that is already in stores and pharmacies.
Facebook Comments
Disqus